Somatic Evolution in Non-neoplastic IBD-Affected Colon

Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation lan...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell Ročník 182; číslo 3; s. 672
Hlavní autoři: Olafsson, Sigurgeir, McIntyre, Rebecca E, Coorens, Tim, Butler, Timothy, Jung, Hyunchul, Robinson, Philip S, Lee-Six, Henry, Sanders, Mathijs A, Arestang, Kenneth, Dawson, Claire, Tripathi, Monika, Strongili, Konstantina, Hooks, Yvette, Stratton, Michael R, Parkes, Miles, Martincorena, Inigo, Raine, Tim, Campbell, Peter J, Anderson, Carl A
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 06.08.2020
Témata:
ISSN:1097-4172, 1097-4172
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation landscape of the normal colon. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon, and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR, ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.
AbstractList Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation landscape of the normal colon. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon, and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR, ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.
Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation landscape of the normal colon. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon, and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR, ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation landscape of the normal colon. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon, and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR, ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.
Author Butler, Timothy
Raine, Tim
Strongili, Konstantina
Hooks, Yvette
Anderson, Carl A
Tripathi, Monika
Sanders, Mathijs A
Jung, Hyunchul
Stratton, Michael R
Campbell, Peter J
Lee-Six, Henry
Arestang, Kenneth
Olafsson, Sigurgeir
McIntyre, Rebecca E
Martincorena, Inigo
Parkes, Miles
Dawson, Claire
Coorens, Tim
Robinson, Philip S
Author_xml – sequence: 1
  givenname: Sigurgeir
  surname: Olafsson
  fullname: Olafsson, Sigurgeir
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 2
  givenname: Rebecca E
  surname: McIntyre
  fullname: McIntyre, Rebecca E
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 3
  givenname: Tim
  surname: Coorens
  fullname: Coorens, Tim
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 4
  givenname: Timothy
  surname: Butler
  fullname: Butler, Timothy
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 5
  givenname: Hyunchul
  surname: Jung
  fullname: Jung, Hyunchul
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 6
  givenname: Philip S
  surname: Robinson
  fullname: Robinson, Philip S
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; University of Cambridge, Department of Paediatrics, Cambridge CB2 0QQ, UK
– sequence: 7
  givenname: Henry
  surname: Lee-Six
  fullname: Lee-Six, Henry
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 8
  givenname: Mathijs A
  surname: Sanders
  fullname: Sanders, Mathijs A
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; Department of Hematology, Erasmus University Medical Center, Postbus 2040, 3000 CA Rotterdam, the Netherlands
– sequence: 9
  givenname: Kenneth
  surname: Arestang
  fullname: Arestang, Kenneth
  organization: Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK
– sequence: 10
  givenname: Claire
  surname: Dawson
  fullname: Dawson, Claire
  organization: Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK
– sequence: 11
  givenname: Monika
  surname: Tripathi
  fullname: Tripathi, Monika
  organization: Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK
– sequence: 12
  givenname: Konstantina
  surname: Strongili
  fullname: Strongili, Konstantina
  organization: Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK
– sequence: 13
  givenname: Yvette
  surname: Hooks
  fullname: Hooks, Yvette
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 14
  givenname: Michael R
  surname: Stratton
  fullname: Stratton, Michael R
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 15
  givenname: Miles
  surname: Parkes
  fullname: Parkes, Miles
  organization: Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK
– sequence: 16
  givenname: Inigo
  surname: Martincorena
  fullname: Martincorena, Inigo
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 17
  givenname: Tim
  surname: Raine
  fullname: Raine, Tim
  organization: Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK
– sequence: 18
  givenname: Peter J
  surname: Campbell
  fullname: Campbell, Peter J
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
– sequence: 19
  givenname: Carl A
  surname: Anderson
  fullname: Anderson, Carl A
  email: carl.anderson@sanger.ac.uk
  organization: Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK. Electronic address: carl.anderson@sanger.ac.uk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32697969$$D View this record in MEDLINE/PubMed
BookMark eNpNj01LxDAYhIOsuB_6BzxIj15a36RN0hzXddWFRQ_quSTpW-jSJrVpBf-9XVzB0wzMwzCzJDPnHRJyTSGhQMXdIbHYNAkDBgmIBFJxRhYUlIwzKtnsn5-TZQgHAMg55xdknjKhpBJqQcSbb_VQ22j75ZtxqL2Lahe9eBc79F2jwzHb3T_E66pCO2AZbXzj3SU5r3QT8OqkK_LxuH3fPMf716fdZr2PLefZEJfaQKq4qnLKwWibAsVMSD1NyrTkFnOrUGnKqcmRSyVZyg2UJgdpSlEiW5Hb396u958jhqFo63B8rad5YyhYxgRPhVDZhN6c0NG0WBZdX7e6_y7-vrIfPQ1XUQ
CitedBy_id crossref_primary_10_1038_s41568_025_00868_x
crossref_primary_10_1172_JCI191855
crossref_primary_10_1016_j_tcb_2021_07_002
crossref_primary_10_1093_intimm_dxac059
crossref_primary_10_1038_s41598_023_34631_9
crossref_primary_10_1146_annurev_cancerbio_061421_012447
crossref_primary_10_1038_s41467_022_29920_2
crossref_primary_10_1073_pnas_2112704118
crossref_primary_10_1158_2159_8290_CD_22_0145
crossref_primary_10_7717_peerj_18347
crossref_primary_10_1093_ecco_jcc_jjab199
crossref_primary_10_1038_s41586_025_08708_6
crossref_primary_10_1146_annurev_cancerbio_070620_091632
crossref_primary_10_1038_s41580_022_00538_y
crossref_primary_10_1186_s40001_023_01566_w
crossref_primary_10_1038_s41588_024_01922_4
crossref_primary_10_1038_s41586_021_03477_4
crossref_primary_10_1038_s41588_021_00930_y
crossref_primary_10_1126_science_abm5874
crossref_primary_10_1038_s12276_023_01140_8
crossref_primary_10_1172_jci_insight_188281
crossref_primary_10_3390_biomedicines8100414
crossref_primary_10_1093_ecco_jcc_jjad025
crossref_primary_10_1016_j_cell_2024_02_009
crossref_primary_10_1002_aac2_12061
crossref_primary_10_1038_s41586_021_03790_y
crossref_primary_10_1038_s41467_022_35592_9
crossref_primary_10_3389_fcell_2021_706755
crossref_primary_10_1038_s41388_023_02802_7
crossref_primary_10_3389_fmed_2021_644333
crossref_primary_10_1136_jcp_2024_209601
crossref_primary_10_1073_pnas_2023373118
crossref_primary_10_3390_ijms241311217
crossref_primary_10_1093_pnasnexus_pgae472
crossref_primary_10_1056_NEJMe2030754
crossref_primary_10_3390_cancers16020374
crossref_primary_10_1038_s41596_020_00437_6
crossref_primary_10_1073_pnas_2019450117
crossref_primary_10_1038_s41586_021_03345_1
crossref_primary_10_1038_s41467_022_31341_0
crossref_primary_10_3390_cancers17020229
crossref_primary_10_1016_j_devcel_2020_11_010
crossref_primary_10_1038_s41568_021_00335_3
crossref_primary_10_1038_s41588_022_01296_5
crossref_primary_10_1038_s41591_025_03623_9
crossref_primary_10_1159_000527340
crossref_primary_10_1186_s13619_022_00143_6
crossref_primary_10_1016_j_stem_2023_05_012
crossref_primary_10_3390_jpm11020151
crossref_primary_10_1038_s41568_025_00838_3
crossref_primary_10_1016_j_devcel_2023_08_011
crossref_primary_10_1016_j_mrrev_2022_108426
crossref_primary_10_1126_science_abh1645
crossref_primary_10_1038_s41588_024_01755_1
crossref_primary_10_1038_s41586_021_03822_7
crossref_primary_10_1056_NEJMra2101920
crossref_primary_10_1146_annurev_physiol_061121_040048
crossref_primary_10_1016_j_tig_2021_06_012
crossref_primary_10_1038_s41431_022_01213_8
crossref_primary_10_1038_s41467_023_40608_z
crossref_primary_10_1093_intimm_dxab048
crossref_primary_10_3389_fmolb_2024_1442611
crossref_primary_10_1016_j_ccell_2022_11_004
crossref_primary_10_3390_jcm13164815
crossref_primary_10_1016_j_ccell_2020_11_002
crossref_primary_10_1016_j_ccell_2023_11_003
crossref_primary_10_1038_s41385_022_00554_3
crossref_primary_10_1038_s41588_023_01537_1
crossref_primary_10_1038_s41598_023_41123_3
crossref_primary_10_1038_s41416_021_01273_5
crossref_primary_10_1038_s41467_024_53332_z
crossref_primary_10_1038_s41586_025_09096_7
crossref_primary_10_1136_gutjnl_2025_335023
crossref_primary_10_3390_genes12111779
crossref_primary_10_3390_cells14080567
crossref_primary_10_1038_s41586_021_03836_1
crossref_primary_10_1038_s41568_022_00529_3
crossref_primary_10_1146_annurev_cancerbio_070620_094029
crossref_primary_10_1016_j_jpedsurg_2024_162116
crossref_primary_10_1016_j_jad_2025_120067
crossref_primary_10_4103_sjg_sjg_124_25
crossref_primary_10_1038_s44319_025_00373_0
crossref_primary_10_1002_aac2_12037
crossref_primary_10_1016_j_jaut_2022_102847
crossref_primary_10_1038_s41568_023_00648_5
crossref_primary_10_1080_1744666X_2023_2157262
crossref_primary_10_1016_j_neo_2021_03_010
crossref_primary_10_3389_fimmu_2023_1048598
crossref_primary_10_1038_s41588_023_01545_1
crossref_primary_10_1016_j_canlet_2024_216831
crossref_primary_10_1038_s12276_021_00680_1
crossref_primary_10_1093_intimm_dxaf020
crossref_primary_10_1038_s41467_022_33663_5
crossref_primary_10_1016_j_tim_2022_05_010
crossref_primary_10_1186_s13104_023_06333_y
crossref_primary_10_1371_journal_pone_0276195
crossref_primary_10_3390_cancers17020219
crossref_primary_10_7759_cureus_82241
crossref_primary_10_1038_s43587_024_00589_0
crossref_primary_10_1038_s41389_023_00492_0
crossref_primary_10_1002_1878_0261_13275
crossref_primary_10_1093_stmcls_sxab020
crossref_primary_10_1038_s12276_022_00912_y
crossref_primary_10_1136_svn_2022_001756
crossref_primary_10_1093_nar_gkab914
crossref_primary_10_1038_s41467_021_21675_6
crossref_primary_10_1038_s41467_022_28568_2
crossref_primary_10_1053_j_gastro_2021_04_042
crossref_primary_10_1016_j_gde_2021_05_005
crossref_primary_10_1038_s41586_024_08133_1
crossref_primary_10_1093_ecco_jcc_jjac101
crossref_primary_10_1111_acel_13613
crossref_primary_10_1038_s41392_024_01848_7
crossref_primary_10_1186_s13046_021_01920_y
crossref_primary_10_1038_s41596_024_00962_8
crossref_primary_10_1016_j_isci_2024_110118
crossref_primary_10_1016_j_jaci_2024_05_008
crossref_primary_10_1165_rcmb_2020_0440TR
crossref_primary_10_1007_s10689_025_00479_3
crossref_primary_10_3390_ijms22052284
crossref_primary_10_1007_s00428_025_04072_y
crossref_primary_10_1007_s11357_024_01113_3
crossref_primary_10_3390_cancers13235915
crossref_primary_10_1007_s10620_020_06609_4
crossref_primary_10_1016_j_arr_2021_101316
crossref_primary_10_1016_j_semcdb_2022_09_006
crossref_primary_10_1126_science_abm3233
crossref_primary_10_3389_fbioe_2022_883791
crossref_primary_10_1161_JAHA_123_032483
crossref_primary_10_3389_fgene_2021_760039
crossref_primary_10_1146_annurev_immunol_101819_075147
ContentType Journal Article
Copyright Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.cell.2020.06.036
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1097-4172
ExternalDocumentID 32697969
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Wellcome Trust
  grantid: 206194
– fundername: Cancer Research UK
  grantid: 21777
GroupedDBID ---
--K
-DZ
-ET
-~X
0R~
0WA
1RT
1~5
29B
2FS
2WC
3EH
4.4
457
4G.
53G
5GY
5RE
62-
6J9
7-5
85S
AAEDT
AAEDW
AAFWJ
AAHBH
AAKRW
AAKUH
AALRI
AAMRU
AAVLU
AAXUO
AAYWO
ABCQX
ABDGV
ABJNI
ABMAC
ABOCM
ACGFO
ACGFS
ACNCT
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
ADXHL
AEFWE
AENEX
AEUPX
AEXQZ
AFPUW
AFTJW
AGCQF
AGHSJ
AGKMS
AHHHB
AIGII
AITUG
AKAPO
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EFKBS
EIF
F5P
FCP
FDB
FIRID
HH5
IH2
IHE
IXB
J1W
JIG
K-O
KOO
KQ8
L7B
LX5
M3Z
M41
N9A
NPM
O-L
O9-
OK1
P2P
RNS
ROL
RPZ
SCP
SDG
SDP
SES
SSZ
TAE
TN5
TR2
TWZ
UKR
UPT
WH7
YZZ
ZCA
7X8
ID FETCH-LOGICAL-c554t-dab03959f8150bac301e467a1724a75ce8c9e9a151b8e5797235b0db807bd6de2
IEDL.DBID 7X8
ISICitedReferencesCount 147
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000558649000013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1097-4172
IngestDate Sat Sep 27 18:53:57 EDT 2025
Mon Jul 21 06:06:38 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords somatic mutations
PIGR
mutational signatures
ZC3H12A
Crohn's disease
mutation rate
ulcerative colitis
IL17
intestinal epithelia
inflammatory bowel disease
Language English
License Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c554t-dab03959f8150bac301e467a1724a75ce8c9e9a151b8e5797235b0db807bd6de2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7427325
PMID 32697969
PQID 2426536694
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2426536694
pubmed_primary_32697969
PublicationCentury 2000
PublicationDate 2020-08-06
PublicationDateYYYYMMDD 2020-08-06
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-06
  day: 06
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell
PublicationTitleAlternate Cell
PublicationYear 2020
SSID ssj0008555
Score 2.649897
Snippet Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 672
SubjectTerms Adult
Aged
Aged, 80 and over
Aging - genetics
Clonal Evolution - genetics
Clonal Evolution - immunology
Colitis - genetics
Colitis - metabolism
Colitis, Ulcerative - genetics
Colitis, Ulcerative - metabolism
Crohn Disease - genetics
Crohn Disease - metabolism
DNA-Binding Proteins - genetics
Epithelial Cells - metabolism
Epithelial Cells - pathology
F-Box-WD Repeat-Containing Protein 7 - genetics
Female
Humans
INDEL Mutation
Inflammatory Bowel Diseases - genetics
Inflammatory Bowel Diseases - immunology
Inflammatory Bowel Diseases - metabolism
Inflammatory Bowel Diseases - pathology
Interleukin-17 - metabolism
Intestinal Mucosa - metabolism
Intestinal Mucosa - pathology
Male
Middle Aged
Mutation Rate
Phylogeny
Point Mutation
Receptors, Cell Surface - genetics
Ribonucleases - genetics
Toll-Like Receptors - genetics
Transcription Factors - genetics
Whole Genome Sequencing
Title Somatic Evolution in Non-neoplastic IBD-Affected Colon
URI https://www.ncbi.nlm.nih.gov/pubmed/32697969
https://www.proquest.com/docview/2426536694
Volume 182
WOSCitedRecordID wos000558649000013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFH-oU_Di93R-UcFrsC5tmpxkzg0FLQMVditJ8wq7tNPNgf-9L2nHToLgpeTQQHh5X3n55f0Ari23t6G2DiplkUVYkM1hIWiE1lD873LrHwo_J2kqx2M1agpuswZWufSJ3lHbKnc18hsXSmIuhIruph_MsUa529WGQmMdWpxSGafVyXjVLVzGnvXUXbKyiCJ182imxne5wjidD7uh79_Jxe8ppg81w93_LnIPdpokM-jVWrEPa1gewFZNO_l9COK18o1ag8GiUbxgUgZpVbLS4cm1a90cPN0_sJ4He6AN-jSzPIL34eCt_8ga_gSWU5IwZ1abkKtYFZKyPqNzsmUkv6hJEpFO4hxlrlBpivlGYpw4_rHYhNbIMDFWWOy2YaOsSjyBwJ3UtEQVaWEjHkmdKBMj_YVaFIaHHbhaCiQj_XSy1bTkr1m2EkkHjmupZtO6kUZGqaNKlFCnf5h9Bttuszz2TpxDqyDrxAvYzBfzyezz0m88fdPRyw-eyLcF
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Somatic+Evolution+in+Non-neoplastic+IBD-Affected+Colon&rft.jtitle=Cell&rft.au=Olafsson%2C+Sigurgeir&rft.au=McIntyre%2C+Rebecca+E&rft.au=Coorens%2C+Tim&rft.au=Butler%2C+Timothy&rft.date=2020-08-06&rft.issn=1097-4172&rft.eissn=1097-4172&rft.volume=182&rft.issue=3&rft.spage=672&rft_id=info:doi/10.1016%2Fj.cell.2020.06.036&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1097-4172&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1097-4172&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1097-4172&client=summon